Neurogene Inc. (NGNE)

USD 16.97

(10.19%)

Total Liabilities Summary of Neurogene Inc.

  • Neurogene Inc.'s latest annual total liabilities in 2023 was 36.54 Million USD , down -85.67% from previous year.
  • Neurogene Inc.'s latest quarterly total liabilities in 2024 Q2 was 24.8 Million USD , up 0.96% from previous quarter.
  • Neurogene Inc. reported annual total liabilities of 255 Million USD in 2022, up 31.88% from previous year.
  • Neurogene Inc. reported annual total liabilities of 193.36 Million USD in 2021, up 901.72% from previous year.
  • Neurogene Inc. reported quarterly total liabilities of 24.57 Million USD for 2024 Q1, down -32.77% from previous quarter.
  • Neurogene Inc. reported quarterly total liabilities of 36.54 Million USD for 2023 FY, down -85.67% from previous quarter.

Annual Total Liabilities Chart of Neurogene Inc. (2023 - 2016)

Historical Annual Total Liabilities of Neurogene Inc. (2023 - 2016)

Year Total Liabilities Total Liabilities Growth
2023 36.54 Million USD -85.67%
2022 255 Million USD 31.88%
2021 193.36 Million USD 901.72%
2020 19.3 Million USD 261.75%
2019 5.33 Million USD 7.89%
2018 4.94 Million USD -56.77%
2017 11.44 Million USD 17.76%
2016 9.71 Million USD 0.0%

Peer Total Liabilities Comparison of Neurogene Inc.

Name Total Liabilities Total Liabilities Difference
Absci Corporation 58.3 Million USD 37.313%
Adaptive Biotechnologies Corporation 352.85 Million USD 89.642%
Alnylam Pharmaceuticals, Inc. 4.05 Billion USD 99.098%
Alzamend Neuro, Inc. 3.22 Million USD -1033.031%
Apollomics, Inc. 14.15 Million USD -158.242%
180 Life Sciences Corp. 5.38 Million USD -578.44%
Atossa Therapeutics, Inc. 5.23 Million USD -598.033%
Bicycle Therapeutics plc 224.41 Million USD 83.713%
Barinthus Biotherapeutics plc 27.51 Million USD -32.852%
BioXcel Therapeutics, Inc. 130.21 Million USD 71.931%
CASI Pharmaceuticals, Inc. 51.1 Million USD 28.48%
Chimerix, Inc. 19.74 Million USD -85.105%
CRISPR Therapeutics AG 346.76 Million USD 89.46%
Contineum Therapeutics, Inc. Class A Common Stock 198.32 Million USD 81.571%
EyePoint Pharmaceuticals, Inc. 88.86 Million USD 58.869%
Fortress Biotech, Inc. 165.93 Million USD 77.974%
Fortress Biotech, Inc. 165.93 Million USD 77.974%
Gritstone bio, Inc. 125.91 Million USD 70.974%
Allakos Inc. 74.79 Million USD 51.133%
Boundless Bio, Inc. Common Stock 256.97 Million USD 85.777%
Cara Therapeutics, Inc. 68.75 Million USD 46.845%
Cytokinetics, Incorporated 1.21 Billion USD 96.981%
enGene Holdings Inc. Common Stock 14.47 Million USD -152.532%
Innoviva, Inc. 568.55 Million USD 93.572%
Hoth Therapeutics, Inc. 704.98 Thousand USD -5084.38%
NLS Pharmaceutics AG 10.68 Million USD -242.213%
RAPT Therapeutics, Inc. 26.29 Million USD -39.001%
Salarius Pharmaceuticals, Inc. 1.29 Million USD -2713.104%
Terns Pharmaceuticals, Inc. 13.15 Million USD -177.939%
Vigil Neuroscience, Inc. 24.6 Million USD -48.537%
ImmuCell Corporation 18.81 Million USD -94.254%
IDEAYA Biosciences, Inc. 28.22 Million USD -29.487%
Incyte Corporation 1.59 Billion USD 97.705%
Inovio Pharmaceuticals, Inc. 55.59 Million USD 34.259%
Lexaria Bioscience Corp. 403.9 Thousand USD -8948.843%
Mustang Bio, Inc. 17.61 Million USD -107.441%
MiMedx Group, Inc. 96.33 Million USD 62.059%
MEI Pharma, Inc. 8.35 Million USD -337.451%
MacroGenics, Inc. 154.2 Million USD 76.299%
Monopar Therapeutics Inc. 1.75 Million USD -1979.728%
Mereo BioPharma Group plc 15.96 Million USD -128.975%
Marker Therapeutics, Inc. 3.07 Million USD -1088.644%
Marinus Pharmaceuticals, Inc. 154.14 Million USD 76.289%
Maravai LifeSciences Holdings, Inc. 697.56 Million USD 94.76%
Minerva Neurosciences, Inc. 85.35 Million USD 57.182%
NeuroBo Pharmaceuticals, Inc. 6.09 Million USD -499.557%
NeuroSense Therapeutics Ltd. 5.05 Million USD -623.743%
NextCure, Inc. 14.99 Million USD -143.709%
Orchestra BioMed Holdings, Inc. 27.16 Million USD -34.525%
Ocuphire Pharma, Inc. 4.04 Million USD -804.231%
Onconetix, Inc. 23.18 Million USD -57.669%
Oncternal Therapeutics, Inc. 6.67 Million USD -447.387%
Opthea Limited 264.6 Million USD 86.187%
Ovid Therapeutics Inc. 56.22 Million USD 35.001%
Psyence Biomedical Ltd. 12.1 Million USD -201.941%
PDS Biotechnology Corporation 33.25 Million USD -9.892%
Precigen, Inc. 41.64 Million USD 12.235%
Pieris Pharmaceuticals, Inc. 11.92 Million USD -206.568%
Prime Medicine, Inc. 60.78 Million USD 39.867%
PureTech Health plc 125.58 Million USD 70.897%
Rocket Pharmaceuticals, Inc. 73.76 Million USD 50.453%
Regeneron Pharmaceuticals, Inc. 7.1 Billion USD 99.486%
Replimune Group, Inc. 113.21 Million USD 67.717%
Revelation Biosciences, Inc. 5.56 Million USD -556.778%
Rigel Pharmaceuticals, Inc. 145.86 Million USD 74.944%
TransCode Therapeutics, Inc. 3.52 Million USD -935.709%
Revolution Medicines, Inc. Warrant 262.39 Million USD 86.071%
Reviva Pharmaceuticals Holdings, Inc. 6.6 Million USD -453.163%
Sesen Bio, Inc. 30.98 Million USD -17.961%
Sangamo Therapeutics, Inc. 82.43 Million USD 55.662%
Solid Biosciences Inc. 38.45 Million USD 4.964%
Syndax Pharmaceuticals, Inc. 58.68 Million USD 37.719%
SciSparc Ltd. 1.59 Million USD -2191.473%
Sutro Biopharma, Inc. 321.08 Million USD 88.617%
TG Therapeutics, Inc. 169.08 Million USD 78.384%
Tonix Pharmaceuticals Holding Corp. 48.93 Million USD 25.307%
Titan Pharmaceuticals, Inc. 1.44 Million USD -2431.094%
Travere Therapeutics, Inc. 588.1 Million USD 93.785%
UroGen Pharma Ltd. 243.52 Million USD 84.992%
Verrica Pharmaceuticals Inc. 61.83 Million USD 40.892%
XOMA Corporation 145.58 Million USD 74.894%
Zentalis Pharmaceuticals, Inc. 124.63 Million USD 70.675%
AbCellera Biologics Inc. 335.77 Million USD 89.115%
Longboard Pharmaceuticals, Inc. 9.77 Million USD -273.941%
Cassava Sciences, Inc. 14.19 Million USD -157.478%
Corbus Pharmaceuticals Holdings, Inc. 35.17 Million USD -3.9%
Precision BioSciences, Inc. 140.92 Million USD 74.064%
Dyadic International, Inc. 2.34 Million USD -1461.489%
Intensity Therapeutics, Inc. 4.13 Million USD -784.321%
Eton Pharmaceuticals, Inc. 16.26 Million USD -124.737%
VYNE Therapeutics Inc. 8.95 Million USD -308.369%
Tenaya Therapeutics, Inc. 31.09 Million USD -17.555%
IGM Biosciences, Inc. 220.17 Million USD 83.4%
X4 Pharmaceuticals, Inc. 96.15 Million USD 61.991%
Acelyrin, Inc. 86.35 Million USD 57.675%
Abeona Therapeutics Inc. 49.17 Million USD 25.677%
Ligand Pharmaceuticals Incorporated 130.7 Million USD 72.037%
Inhibikase Therapeutics, Inc. 3.52 Million USD -935.757%
Arcturus Therapeutics Holdings Inc. 150.88 Million USD 75.778%
Syros Pharmaceuticals, Inc. 151.51 Million USD 75.877%
Senti Biosciences, Inc. 52.57 Million USD 30.477%
Mesoblast Limited 188.79 Million USD 80.641%
Kymera Therapeutics, Inc. 180.78 Million USD 79.784%
ChromaDex Corporation 26.5 Million USD -37.879%
BriaCell Therapeutics Corp. 8.55 Million USD -327.114%
Akebia Therapeutics, Inc. 272.28 Million USD 86.577%
Dermata Therapeutics, Inc. 1.62 Million USD -2151.086%
Seer, Inc. 39.36 Million USD 7.154%
Xeris Biopharma Holdings, Inc. 347.58 Million USD 89.485%
Novavax, Inc. 2.57 Billion USD 98.579%
Virpax Pharmaceuticals, Inc. 7.69 Million USD -375.031%
Fate Therapeutics, Inc. 137.8 Million USD 73.477%
Checkpoint Therapeutics, Inc. 18.42 Million USD -98.366%
Lyell Immunopharma, Inc. 95.07 Million USD 61.559%
Celcuity Inc. 51.45 Million USD 28.962%
ContextLogic Inc. 206 Million USD 82.258%
Phathom Pharmaceuticals, Inc. 486.6 Million USD 92.489%
HOOKIPA Pharma Inc. 71.48 Million USD 48.868%
Jazz Pharmaceuticals plc 7.65 Billion USD 99.523%
Amarin Corporation plc 279.58 Million USD 86.928%
AnaptysBio, Inc. 364.28 Million USD 89.967%
Aptevo Therapeutics Inc. 12.62 Million USD -189.589%
Aptorum Group Limited 5.25 Million USD -595.279%
Cartesian Therapeutics, Inc. 745.23 Million USD 95.096%
Arrowhead Pharmaceuticals, Inc. 478.39 Million USD 92.36%
Ardelyx, Inc. 130.76 Million USD 72.049%
Celularity Inc. 102.92 Million USD 64.491%
Omeros Corporation 403.25 Million USD 90.936%
Humacyte, Inc. 114.67 Million USD 68.129%
Immunocore Holdings plc 228.15 Million USD 83.981%
IO Biotech, Inc. 17.55 Million USD -108.185%
GT Biopharma, Inc. 6.63 Million USD -451.018%
Cabaletta Bio, Inc. 17.45 Million USD -109.426%
Summit Therapeutics Inc. 125.25 Million USD 70.821%
Alaunos Therapeutics, Inc. 1.95 Million USD -1768.558%
Pulmatrix, Inc. 15.96 Million USD -128.961%
Intellia Therapeutics, Inc. 250.8 Million USD 85.427%
Evogene Ltd. 17.99 Million USD -103.163%
CorMedix Inc. 11.91 Million USD -206.683%
BioLineRx Ltd. 50.7 Million USD 27.914%
VistaGen Therapeutics, Inc. 9.36 Million USD -290.189%
Sagimet Biosciences Inc. 5.65 Million USD -546.427%
PTC Therapeutics, Inc. 2.72 Billion USD 98.657%
scPharmaceuticals Inc. 57.26 Million USD 36.171%
Fulcrum Therapeutics, Inc. 22.5 Million USD -62.433%
Corcept Therapeutics Incorporated 114.81 Million USD 68.166%
NLS Pharmaceutics AG 10.68 Million USD -242.213%
Reviva Pharmaceuticals Holdings, Inc. 6.6 Million USD -453.163%
Akero Therapeutics, Inc. 44.96 Million USD 18.717%
Eliem Therapeutics, Inc. 2.87 Million USD -1173.484%
Lisata Therapeutics, Inc. 6.8 Million USD -437.485%
Stoke Therapeutics, Inc. 68.77 Million USD 46.859%
Reneo Pharmaceuticals, Inc. 18.82 Million USD -94.141%
Outlook Therapeutics, Inc. 46.73 Million USD 21.802%
ProMIS Neurosciences, Inc. 12.38 Million USD -195.035%
Daré Bioscience, Inc. 26.32 Million USD -38.812%
bluebird bio, Inc. 424.62 Million USD 91.393%
BioMarin Pharmaceutical Inc. 1.89 Billion USD 98.066%
DBV Technologies S.A. 42.8 Million USD 14.605%
Avidity Biosciences, Inc. 127.79 Million USD 71.399%
Galecto, Inc. 5.89 Million USD -519.895%
Sensei Biotherapeutics, Inc. 9.47 Million USD -285.579%
Spruce Biosciences, Inc. 27.43 Million USD -33.211%
Inhibrx Biosciences, Inc. 264.39 Million USD 86.176%
GlycoMimetics, Inc. 6.9 Million USD -429.536%
Arcutis Biotherapeutics, Inc. 252.69 Million USD 85.536%
ADMA Biologics, Inc. 193.97 Million USD 81.158%
Clene Inc. 38.95 Million USD 6.167%
Recursion Pharmaceuticals, Inc. 190.26 Million USD 80.79%
Aptose Biosciences Inc. 15.8 Million USD -131.195%
ZyVersa Therapeutics, Inc. 11.03 Million USD -231.069%
Soligenix, Inc. 7.27 Million USD -402.398%
Century Therapeutics, Inc. 175.94 Million USD 79.227%
Kura Oncology, Inc. 51.66 Million USD 29.254%
Surrozen, Inc. 8.14 Million USD -348.729%
TScan Therapeutics, Inc. 121.28 Million USD 69.864%
Ocean Biomedical, Inc. 6.61 Million USD -452.613%
CytomX Therapeutics, Inc. 252.59 Million USD 85.531%
Autolus Therapeutics plc 263.9 Million USD 86.151%
Mineralys Therapeutics, Inc. 10.48 Million USD -248.683%
Eterna Therapeutics Inc. 46.89 Million USD 22.069%
Caribou Biosciences, Inc. 72.56 Million USD 49.634%
GRI Bio, Inc. 2.69 Million USD -1255.172%
Xenetic Biosciences, Inc. 809.58 Thousand USD -4414.535%
Janux Therapeutics, Inc. 36.05 Million USD -1.362%
INmune Bio, Inc. 18.86 Million USD -93.771%
Heron Therapeutics, Inc. 256.47 Million USD 85.75%
SAB Biotherapeutics, Inc. 26.64 Million USD -37.187%
Pasithea Therapeutics Corp. 2.71 Million USD -1244.501%
Tenax Therapeutics, Inc. 3.58 Million USD -919.066%
Jaguar Health, Inc. 45.86 Million USD 20.314%
Entero Therapeutics, Inc. 3.28 Million USD -1014.208%
Milestone Pharmaceuticals Inc. 58.45 Million USD 37.475%
Clearside Biomedical, Inc. 49.93 Million USD 26.8%
Atara Biotherapeutics, Inc. 264.73 Million USD 86.194%
Coherus BioSciences, Inc. 823.02 Million USD 95.559%
Verastem, Inc. 71.18 Million USD 48.656%
Pliant Therapeutics, Inc. 38.57 Million USD 5.259%
Histogen Inc. 5.69 Million USD -541.548%
Aprea Therapeutics, Inc. 4.38 Million USD -733.386%
ACADIA Pharmaceuticals Inc. 317.2 Million USD 88.478%
Surrozen, Inc. 8.14 Million USD -348.729%
Organovo Holdings, Inc. 2.74 Million USD -1230.022%
Lixte Biotechnology Holdings, Inc. 313.85 Thousand USD -11545.075%
Cadrenal Therapeutics, Inc. Common Stock 826.87 Thousand USD -4320.136%
Centessa Pharmaceuticals plc 126.72 Million USD 71.159%
Hepion Pharmaceuticals, Inc. 10.81 Million USD -237.991%
BioRestorative Therapies, Inc. 2.6 Million USD -1301.771%
Kronos Bio, Inc. 54.2 Million USD 32.568%
Turnstone Biologics Corp. 14.14 Million USD -158.333%
Synaptogenix, Inc. 5.52 Million USD -560.986%
Tiziana Life Sciences Ltd 6.64 Million USD -449.774%
Entrada Therapeutics, Inc. 226.83 Million USD 83.887%
Aurinia Pharmaceuticals Inc. 170.1 Million USD 78.514%
Exelixis, Inc. 678.44 Million USD 94.613%
Nurix Therapeutics, Inc. 164.04 Million USD 77.72%
Apellis Pharmaceuticals, Inc. 594.2 Million USD 93.849%
Jasper Therapeutics, Inc. 14.67 Million USD -149.039%
ESSA Pharma Inc. 3.49 Million USD -945.73%
TNF Pharmaceuticals, Inc. 5.08 Million USD -618.249%
Avid Bioservices, Inc. 275.66 Million USD 86.742%
Insmed Incorporated 1.66 Billion USD 97.801%
MediWound Ltd. 27.18 Million USD -34.436%
OmniAb, Inc. 87.4 Million USD 58.182%
Alector, Inc. 487.66 Million USD 92.505%
Seres Therapeutics, Inc. 403.45 Million USD 90.941%
Zai Lab Limited 240.17 Million USD 84.782%
AlloVir, Inc. 45.01 Million USD 18.807%
Revance Therapeutics, Inc. 630.05 Million USD 94.199%
ORIC Pharmaceuticals, Inc. 30.59 Million USD -19.449%
Aura Biosciences, Inc. 29.22 Million USD -25.052%
Immunic, Inc. 25.36 Million USD -44.075%
Tarsus Pharmaceuticals, Inc. 69.23 Million USD 47.211%
Veracyte, Inc. 93.71 Million USD 61.002%
InMed Pharmaceuticals Inc. 2.61 Million USD -1296.774%
FibroGen, Inc. 585.72 Million USD 93.76%
SeaStar Medical Holding Corporation 17.38 Million USD -110.257%
Catalyst Pharmaceuticals, Inc. 84.02 Million USD 56.503%
Adial Pharmaceuticals, Inc. 653.07 Thousand USD -5496.439%
Sonnet BioTherapeutics Holdings, Inc. 5.65 Million USD -546.261%
Cyclacel Pharmaceuticals, Inc. 8.19 Million USD -345.828%
Amylyx Pharmaceuticals, Inc. 84.02 Million USD 56.501%
Fortrea Holdings Inc. 2.61 Billion USD 98.604%
KalVista Pharmaceuticals, Inc. 28.82 Million USD -26.809%
XBiotech Inc. 8.39 Million USD -335.263%
Jasper Therapeutics, Inc. 14.67 Million USD -149.039%
Keros Therapeutics, Inc. 37.81 Million USD 3.34%
SELLAS Life Sciences Group, Inc. 14.37 Million USD -154.183%
Lyra Therapeutics, Inc. 53.18 Million USD 31.273%
Foghorn Therapeutics Inc. 363.1 Million USD 89.934%
Agenus Inc. 462.29 Million USD 92.094%
Y-mAbs Therapeutics, Inc. 26.88 Million USD -35.951%
Theravance Biopharma, Inc. 169 Million USD 78.374%
Ultragenyx Pharmaceutical Inc. 1.21 Billion USD 96.993%
Metagenomi, Inc. Common Stock 500.42 Million USD 92.696%
BioCryst Pharmaceuticals, Inc. 972.48 Million USD 96.242%
Gain Therapeutics, Inc. 6.03 Million USD -506.008%
C4 Therapeutics, Inc. 130.33 Million USD 71.958%
Creative Medical Technology Holdings, Inc. 371.39 Thousand USD -9741.031%
Chemomab Therapeutics Ltd. 5.15 Million USD -609.134%
Lantern Pharma Inc. 2.73 Million USD -1234.06%
Eledon Pharmaceuticals, Inc. 42.47 Million USD 13.952%
Ainos, Inc. 7.39 Million USD -394.291%
Pluri Inc. 34.11 Million USD -7.144%
Prothena Corporation plc 135.01 Million USD 72.93%
Adaptimmune Therapeutics plc 243.1 Million USD 84.966%
Rallybio Corporation 9.43 Million USD -287.336%
Kodiak Sciences Inc. 213.59 Million USD 82.888%
Cue Biopharma, Inc. 24.44 Million USD -49.515%
MeiraGTx Holdings plc 319.99 Million USD 88.578%
Annexon, Inc. 47.11 Million USD 22.431%
Assembly Biosciences, Inc. 96.37 Million USD 62.075%
Moderna, Inc. 4.57 Billion USD 99.201%
Cocrystal Pharma, Inc. 4.87 Million USD -649.723%
Cidara Therapeutics, Inc. 76.74 Million USD 52.373%
Blueprint Medicines Corporation 918.64 Million USD 96.021%
Immix Biopharma, Inc. 3.72 Million USD -882.029%
CalciMedica, Inc. 4.02 Million USD -807.373%
Monte Rosa Therapeutics, Inc. 124.5 Million USD 70.645%
Scholar Rock Holding Corporation 85.81 Million USD 57.411%
Wave Life Sciences Ltd. 227.44 Million USD 83.931%
Sana Biotechnology, Inc. 277.79 Million USD 86.843%
Elicio Therapeutics, Inc. 15.77 Million USD -131.719%
Adlai Nortye Ltd. American Depositary Shares 50.78 Million USD 28.033%
Nutriband Inc. 1.07 Million USD -3287.557%
Protara Therapeutics, Inc. 10.63 Million USD -243.732%
Vor Biopharma Inc. 59.1 Million USD 38.162%
Roivant Sciences Ltd. 773.95 Million USD 95.278%
Alkermes plc 933.53 Million USD 96.085%
ProKidney Corp. 29.21 Million USD -25.099%
Applied Therapeutics, Inc. 71.97 Million USD 49.223%
Arcellx, Inc. 339.75 Million USD 89.242%
BridgeBio Pharma, Inc. 1.88 Billion USD 98.065%
Tango Therapeutics, Inc. 149.45 Million USD 75.546%
Galectin Therapeutics Inc. 88.44 Million USD 58.674%
Atai Life Sciences N.V. 49.16 Million USD 25.656%
Renovaro Biosciences Inc. 31.15 Million USD -17.324%
Aerovate Therapeutics, Inc. 17.96 Million USD -103.48%
MediciNova, Inc. 3.89 Million USD -839.188%
Praxis Precision Medicines, Inc. 18.27 Million USD -99.951%
Cardio Diagnostics Holdings, Inc. 1.5 Million USD -2329.73%
GeoVax Labs, Inc. 3.51 Million USD -938.359%
Axsome Therapeutics, Inc. 397.25 Million USD 90.8%
Biomea Fusion, Inc. 30.69 Million USD -19.091%
RenovoRx, Inc. 4.46 Million USD -718.383%
Cullinan Oncology, Inc. 31.2 Million USD -17.14%
Geron Corporation 146.12 Million USD 74.988%
NRx Pharmaceuticals, Inc. 19.04 Million USD -91.878%
4D Molecular Therapeutics, Inc. 32.06 Million USD -13.995%
Dyne Therapeutics, Inc. 73.79 Million USD 50.469%
Kiniksa Pharmaceuticals, Ltd. 87.48 Million USD 58.222%
Royalty Pharma plc 6.29 Billion USD 99.42%
Ventyx Biosciences, Inc. 33.77 Million USD -8.229%
Imunon, Inc. 8.53 Million USD -328.455%
BioAtla, Inc. 48.98 Million USD 25.389%
Allogene Therapeutics, Inc. 130.6 Million USD 72.015%
Larimar Therapeutics, Inc. 14.21 Million USD -157.116%
Mersana Therapeutics, Inc. 189.15 Million USD 80.678%
Structure Therapeutics Inc. 29.05 Million USD -25.81%
89bio, Inc. 59.96 Million USD 39.047%
Kezar Life Sciences, Inc. 33.66 Million USD -8.567%
aTyr Pharma, Inc. 31.59 Million USD -15.672%
Aligos Therapeutics, Inc. 61.82 Million USD 40.881%
Viridian Therapeutics, Inc. 48.4 Million USD 24.489%
EyeGate Pharmaceuticals, Inc. 8.15 Million USD -348.013%
Akari Therapeutics, Plc 4.58 Million USD -697.317%
Tevogen Bio Holdings Inc. 17.73 Million USD -106.106%
Halozyme Therapeutics, Inc. 1.64 Billion USD 97.784%
Lexicon Pharmaceuticals, Inc. 136.31 Million USD 73.189%
Liquidia Corporation 73.13 Million USD 50.027%
Entera Bio Ltd. 1.37 Million USD -2550.399%
GH Research PLC 6.7 Million USD -445.426%
Vericel Corporation 127.7 Million USD 71.38%
Arbutus Biopharma Corporation 38.38 Million USD 4.778%
Xencor, Inc. 283.55 Million USD 87.111%
60 Degrees Pharmaceuticals, Inc. 2.98 Million USD -1124.145%
Pasithea Therapeutics Corp. 2.71 Million USD -1244.501%
Coeptis Therapeutics Holdings, Inc. 3.75 Million USD -872.792%
Vaxcyte, Inc. 167.44 Million USD 78.173%
Xenon Pharmaceuticals Inc. 36.87 Million USD 0.889%
Vanda Pharmaceuticals Inc. 103.53 Million USD 64.697%
Lexaria Bioscience Corp. 403.9 Thousand USD -8948.843%
Portage Biotech Inc. 4.45 Million USD -721.326%
Cardio Diagnostics Holdings, Inc. 1.5 Million USD -2329.73%
Olema Pharmaceuticals, Inc. 23.05 Million USD -58.564%
OncoCyte Corporation 49.29 Million USD 25.861%
Qualigen Therapeutics, Inc. 4.13 Million USD -783.508%
Processa Pharmaceuticals, Inc. 797.48 Thousand USD -4483.039%
Purple Biotech Ltd. 10 Million USD -265.307%
Tempest Therapeutics, Inc. 24.83 Million USD -47.167%
Sol-Gel Technologies Ltd. 6.64 Million USD -450.188%
Rhythm Pharmaceuticals, Inc. 162.98 Million USD 77.575%
CollPlant Biotechnologies Ltd. 5.78 Million USD -531.68%
Moleculin Biotech, Inc. 12.14 Million USD -200.963%
United Therapeutics Corporation 1.18 Billion USD 96.908%
HilleVax, Inc. 78.9 Million USD 53.682%
Silo Pharma, Inc. 1.56 Million USD -2229.045%
Telomir Pharmaceuticals, Inc. Common Stock 1.33 Million USD -2636.597%
Pharming Group N.V. 244.07 Million USD 85.025%
Tharimmune, Inc. 1.81 Million USD -1913.668%
Genprex, Inc. 3.25 Million USD -1023.13%
Apogee Therapeutics, Inc. 21.49 Million USD -70.067%
Neumora Therapeutics, Inc. Common Stock 27.11 Million USD -34.773%
Pyxis Oncology, Inc. 48.02 Million USD 23.891%
XTL Biopharmaceuticals Ltd. 206 Thousand USD -17642.233%
Virios Therapeutics, Inc. 358.54 Thousand USD -10093.614%
OKYO Pharma Limited 7.42 Million USD -392.518%
Savara Inc. 37.19 Million USD 1.729%
Windtree Therapeutics, Inc. 29.01 Million USD -25.966%
Curis, Inc. 57.61 Million USD 36.56%
Carmell Therapeutics Corporation 39.19 Million USD 6.762%
Achieve Life Sciences, Inc. 20.81 Million USD -75.556%
BeiGene, Ltd. 2.23 Billion USD 98.364%
Protagonist Therapeutics, Inc. 21.27 Million USD -71.801%
Erasca, Inc. 78.61 Million USD 53.507%
Protagenic Therapeutics, Inc. 655.25 Thousand USD -5477.854%
Protagenic Therapeutics, Inc. 655.25 Thousand USD -5477.854%
Vincerx Pharma, Inc. 6.99 Million USD -422.502%
Fresh Tracks Therapeutics, Inc. 1.65 Million USD -2107.065%
Acrivon Therapeutics, Inc. Common Stock 17.07 Million USD -114.112%
Celldex Therapeutics, Inc. 36.45 Million USD -0.255%
Cogent Biosciences, Inc. 55.63 Million USD 34.306%
Adicet Bio, Inc. 37.12 Million USD 1.538%
Amicus Therapeutics, Inc. 617.7 Million USD 94.083%
Aditxt, Inc. 28.53 Million USD -28.1%
Adagene Inc. 45.16 Million USD 19.084%
Estrella Immunopharma, Inc. 180.7 Thousand USD -20126.23%
Quantum-Si incorporated 26.63 Million USD -37.242%
Acurx Pharmaceuticals, Inc. 3.04 Million USD -1101.306%
Voyager Therapeutics, Inc. 114.96 Million USD 68.207%
Compugen Ltd. 55.77 Million USD 34.471%
Generation Bio Co. 171.63 Million USD 78.705%
Astria Therapeutics, Inc. 11.55 Million USD -216.442%
Black Diamond Therapeutics, Inc. 41.83 Million USD 12.627%
Invivyd, Inc. 51.71 Million USD 29.323%
Relay Therapeutics, Inc. 91.97 Million USD 60.263%
Quoin Pharmaceuticals, Ltd. 6.5 Million USD -461.838%
Spero Therapeutics, Inc. 75.49 Million USD 51.588%
Artelo Biosciences, Inc. 1.02 Million USD -3479.726%
2seventy bio, Inc. 310.12 Million USD 88.215%
Instil Bio, Inc. 99.8 Million USD 63.378%
Capricor Therapeutics, Inc. 36.13 Million USD -1.152%
Elevai Labs, Inc. Common Stock 1.36 Million USD -2581.822%
GeoVax Labs, Inc. 3.51 Million USD -938.359%
Citius Pharmaceuticals, Inc. 12.17 Million USD -200.082%
Relmada Therapeutics, Inc. 12.19 Million USD -199.71%
ALX Oncology Holdings Inc. 52.84 Million USD 30.832%
Vir Biotechnology, Inc. 369.85 Million USD 90.118%
Evaxion Biotech A/S 17.61 Million USD -107.459%
Ocular Therapeutix, Inc. 160.92 Million USD 77.289%
Verve Therapeutics, Inc. 153.18 Million USD 76.141%
Tyra Biosciences, Inc. 21.59 Million USD -69.248%
Cingulate Inc. 10.36 Million USD -252.76%
Galmed Pharmaceuticals Ltd. 2.75 Million USD -1229.055%
Unity Biotechnology, Inc. 37.29 Million USD 1.992%
Connect Biopharma Holdings Limited 24.84 Million USD -47.084%
Clearmind Medicine Inc. 3.61 Million USD -912.435%
Bolt Biotherapeutics, Inc. 47.04 Million USD 22.307%
CERo Therapeutics Holdings, Inc. 22.75 Million USD -60.586%
Viking Therapeutics, Inc. 20.07 Million USD -82.099%
Madrigal Pharmaceuticals, Inc. 235.21 Million USD 84.461%
ImmunityBio, Inc. 1.09 Billion USD 96.648%
Korro Bio, Inc. 51.75 Million USD 29.377%
Kineta, Inc. 7.22 Million USD -406.079%
BioVie Inc. 9.7 Million USD -276.711%
Codexis, Inc. 49.94 Million USD 26.823%
Celularity Inc. 102.92 Million USD 64.491%
Aileron Therapeutics, Inc. 112.39 Million USD 67.483%
Crinetics Pharmaceuticals, Inc. 96.24 Million USD 62.026%
Virax Biolabs Group Limited 345.19 Thousand USD -10487.959%
Cibus, Inc. 206.11 Million USD 82.268%
IN8bio, Inc. 8.77 Million USD -316.655%
Adverum Biotechnologies, Inc. 89.54 Million USD 59.182%
Avalo Therapeutics, Inc. 13.68 Million USD -166.995%
Ionis Pharmaceuticals, Inc. 2.6 Billion USD 98.596%
Eyenovia, Inc. 19.78 Million USD -84.775%
Puma Biotechnology, Inc. 177.08 Million USD 79.361%
Conduit Pharmaceuticals Inc. 7.68 Million USD -375.836%
Elevation Oncology, Inc. 34.28 Million USD -6.613%
Xilio Therapeutics, Inc. 24.09 Million USD -51.662%
Cardiff Oncology, Inc. 11.89 Million USD -207.186%
Enanta Pharmaceuticals, Inc. 245.54 Million USD 85.115%
Regulus Therapeutics Inc. 9.56 Million USD -282.192%
Moolec Science SA 13.94 Million USD -162.087%
Acumen Pharmaceuticals, Inc. 43.15 Million USD 15.302%
LAVA Therapeutics N.V. 50.53 Million USD 27.672%
Atea Pharmaceuticals, Inc. 39.77 Million USD 8.113%
Compass Therapeutics, Inc. 8.33 Million USD -338.395%
Greenwich LifeSciences, Inc. 294.4 Thousand USD -12314.489%
TFF Pharmaceuticals, Inc. 2.46 Million USD -1385.561%
Humacyte, Inc. 114.67 Million USD 68.129%
PMV Pharmaceuticals, Inc. 26.46 Million USD -38.114%
Avenue Therapeutics, Inc. 1.19 Million USD -2955.936%
Genelux Corporation 8.42 Million USD -334.074%
Trevi Therapeutics, Inc. 6.85 Million USD -433.095%
Notable Labs, Ltd. 4.42 Million USD -725.593%
Immunovant, Inc. 48.95 Million USD 25.342%
Quantum-Si incorporated 26.63 Million USD -37.242%
DiaMedica Therapeutics Inc. 3.1 Million USD -1077.86%
Vera Therapeutics, Inc. 73.86 Million USD 50.517%
Acasti Pharma Inc. 11.55 Million USD -216.25%
MiNK Therapeutics, Inc. 22.6 Million USD -61.666%
Soleno Therapeutics, Inc. 23.18 Million USD -57.648%
PepGen Inc. 34.63 Million USD -5.538%
Nuvectis Pharma, Inc. 6.98 Million USD -423.325%
BriaCell Therapeutics Corp. 8.55 Million USD -327.114%
Immuneering Corporation 12 Million USD -204.363%
Lixte Biotechnology Holdings, Inc. 313.85 Thousand USD -11545.075%
Belite Bio, Inc 4.21 Million USD -767.941%
XOMA Corporation 145.58 Million USD 74.894%
ARS Pharmaceuticals, Inc. 2.42 Million USD -1405.313%
Bionomics Limited 10.15 Million USD -259.78%
Alpha Tau Medical Ltd. 22.91 Million USD -59.512%
uniQure N.V. 624.01 Million USD 94.143%
Estrella Immunopharma, Inc. 180.7 Thousand USD -20126.23%
Poseida Therapeutics, Inc. 170.18 Million USD 78.524%
Forte Biosciences, Inc. 3.66 Million USD -896.972%
Anebulo Pharmaceuticals, Inc. 260.58 Thousand USD -13925.857%
Enlivex Therapeutics Ltd. 6.74 Million USD -441.707%
Conduit Pharmaceuticals Inc. 7.68 Million USD -375.836%
SeaStar Medical Holding Corporation 17.38 Million USD -110.257%
FibroBiologics, Inc. Common Stock 10.56 Million USD -245.846%
Altimmune, Inc. 16.54 Million USD -120.96%
LENZ Therapeutics, Inc. 4.87 Million USD -649.877%
Alpha Tau Medical Ltd. 22.91 Million USD -59.512%
Peak Bio, Inc. 20.75 Million USD -76.111%
Zevra Therapeutics, Inc. 110.46 Million USD 66.913%
Benitec Biopharma Inc. 4.96 Million USD -636.578%
Spyre Therapeutics, Inc. 157.84 Million USD 76.845%
NKGen Biotech, Inc. Common Stock 75.17 Million USD 51.381%
Zura Bio Limited 21.29 Million USD -71.656%
PolyPid Ltd. 17.46 Million USD -109.234%
NKGen Biotech, Inc. Warrants 75.17 Million USD 51.381%
argenx SE 444.95 Million USD 91.786%
Immunome, Inc. 28.65 Million USD -27.535%
Verona Pharma plc 58.84 Million USD 37.885%
enGene Holdings Inc. Warrants 14.47 Million USD -152.532%
Shattuck Labs, Inc. 14.85 Million USD -145.972%
CervoMed Inc. 2.59 Million USD -1308.034%
Plus Therapeutics, Inc. 12.73 Million USD -186.974%
Dianthus Therapeutics, Inc. 10.53 Million USD -246.929%
Moolec Science SA 13.94 Million USD -162.087%
Enveric Biosciences, Inc. 2.34 Million USD -1459.588%
Design Therapeutics, Inc. 11.95 Million USD -205.696%
Leap Therapeutics, Inc. 12.68 Million USD -188.15%
Seelos Therapeutics, Inc. 38.92 Million USD 6.111%
Achilles Therapeutics plc 19.08 Million USD -91.486%
CERo Therapeutics Holdings, Inc. 22.75 Million USD -60.586%
CG Oncology, Inc. Common stock 14.51 Million USD -151.871%
Fractyl Health, Inc. Common Stock 401.27 Million USD 90.892%
Rani Therapeutics Holdings, Inc. 32.47 Million USD -12.552%
MoonLake Immunotherapeutics 13.04 Million USD -180.088%
Tourmaline Bio, Inc. 5.25 Million USD -595.774%
Beam Therapeutics Inc. 478.38 Million USD 92.36%
Mirum Pharmaceuticals, Inc. 397.95 Million USD 90.816%
AEON Biopharma, Inc. 159.88 Million USD 77.141%
Aadi Bioscience, Inc. 27.22 Million USD -34.233%
Enliven Therapeutics, Inc. 25.96 Million USD -40.784%
Kiora Pharmaceuticals, Inc. 7.6 Million USD -380.768%
NeurAxis, Inc. 1.91 Million USD -1810.82%
Iovance Biotherapeutics, Inc. 195.73 Million USD 81.328%
Lumos Pharma, Inc. 13.33 Million USD -174.124%
Opiant Pharmaceuticals, Inc. 23.58 Million USD -54.947%
Palisade Bio, Inc. 2.73 Million USD -1234.392%
Nutriband Inc. 1.07 Million USD -3287.557%
Taysha Gene Therapies, Inc. 192.05 Million USD 80.97%
Kintara Therapeutics, Inc. 2.44 Million USD -1394.847%
CARGO Therapeutics, Inc. Common Stock 47.65 Million USD 23.297%
Athira Pharma, Inc. 30.05 Million USD -21.599%
HCW Biologics Inc. 15.05 Million USD -142.819%
XOMA Corporation 145.58 Million USD 74.894%
Nektar Therapeutics 267.04 Million USD 86.314%
Arvinas, Inc. 644.6 Million USD 94.33%
Tevogen Bio Holdings Inc. 17.73 Million USD -106.106%
Merus N.V. 102.15 Million USD 64.221%
Omega Therapeutics, Inc. 146.35 Million USD 75.026%
Quince Therapeutics, Inc. 95.12 Million USD 61.576%
Rezolute, Inc. 11.73 Million USD -211.479%
Clene Inc. 38.95 Million USD 6.167%
Indaptus Therapeutics, Inc. 2.84 Million USD -1183.601%
BeyondSpring Inc. 48.26 Million USD 24.281%
Synlogic, Inc. 32.89 Million USD -11.108%
Allarity Therapeutics, Inc. 14.61 Million USD -150.113%
Phio Pharmaceuticals Corp. 1.63 Million USD -2136.781%
Peak Bio, Inc. 20.75 Million USD -76.111%
Werewolf Therapeutics, Inc. 63.45 Million USD 42.405%
Krystal Biotech, Inc. 39.71 Million USD 7.969%
Karyopharm Therapeutics Inc. 376.64 Million USD 90.296%
SpringWorks Therapeutics, Inc. 99.56 Million USD 63.293%
Lipella Pharmaceuticals Inc. 432.72 Thousand USD -8346.222%
MannKind Corporation 721.36 Million USD 94.933%
Ikena Oncology, Inc. 22.33 Million USD -63.64%
Cyclerion Therapeutics, Inc. 2.08 Million USD -1652.109%
Gyre Therapeutics, Inc. 102.59 Million USD 64.374%
Gossamer Bio, Inc. 249.14 Million USD 85.33%
CohBar, Inc. 1.03 Million USD -3435.957%
Cognition Therapeutics, Inc. 10.68 Million USD -241.931%
NRx Pharmaceuticals, Inc. 19.04 Million USD -91.878%
Legend Biotech Corporation 589.93 Million USD 93.805%
Mural Oncology plc 37.92 Million USD 3.636%
Disc Medicine, Inc. 22.87 Million USD -59.777%
Champions Oncology, Inc. 28.03 Million USD -30.369%
REGENXBIO Inc. 262.22 Million USD 86.062%
Ensysce Biosciences, Inc. 3.35 Million USD -987.978%
Anavex Life Sciences Corp. 12.53 Million USD -191.599%
Cellectar Biosciences, Inc. 13.43 Million USD -172.111%
Edgewise Therapeutics, Inc. 21.2 Million USD -72.36%
Vaxart, Inc. 34.02 Million USD -7.418%
PharmaCyte Biotech, Inc. 20.38 Million USD -79.256%
Aldeyra Therapeutics, Inc. 28.53 Million USD -28.099%
Cellectis S.A. 249.57 Million USD 85.356%
Longeveron Inc. 5.33 Million USD -584.823%
Repare Therapeutics Inc. 41.81 Million USD 12.602%
Sarepta Therapeutics, Inc. 2.4 Billion USD 98.48%
Inozyme Pharma, Inc. 60.36 Million USD 39.456%
Revolution Medicines, Inc. 262.39 Million USD 86.071%
Nymox Pharmaceutical Corporation 2.1 Million USD -1634.646%
Third Harmonic Bio, Inc. 8.62 Million USD -323.707%
ArriVent BioPharma, Inc. Common Stock 11.8 Million USD -209.711%
AN2 Therapeutics, Inc. 14.04 Million USD -160.265%
Anixa Biosciences, Inc. 2.15 Million USD -1599.163%
Vertex Pharmaceuticals Incorporated 5.14 Billion USD 99.29%
Denali Therapeutics Inc. 122.96 Million USD 70.276%
Revelation Biosciences, Inc. 5.56 Million USD -556.778%
Veru Inc. 32.81 Million USD -11.387%
Corvus Pharmaceuticals, Inc. 6.86 Million USD -432.086%
Cingulate Inc. 10.36 Million USD -252.76%
Passage Bio, Inc. 39.26 Million USD 6.91%
Context Therapeutics Inc. 4.19 Million USD -771.934%
Exicure, Inc. 8.54 Million USD -327.524%
Day One Biopharmaceuticals, Inc. 29.5 Million USD -23.861%
Oramed Pharmaceuticals Inc. 10.48 Million USD -248.55%
Scinai Immunotherapeutics Ltd. 22.04 Million USD -65.823%
Nuvalent, Inc. 31.82 Million USD -14.851%
ABVC BioPharma, Inc. 6.36 Million USD -474.523%
Carisma Therapeutics, Inc. 63.02 Million USD 42.006%
Unicycive Therapeutics, Inc. 18 Million USD -103.05%
OmniAb, Inc. 87.4 Million USD 58.182%
Anew Medical, Inc. 8.24 Million USD -343.459%
Fennec Pharmaceuticals Inc. 38.28 Million USD 4.545%
Lipocine Inc. 2.63 Million USD -1288.836%
Lexeo Therapeutics, Inc. Common Stock 26.27 Million USD -39.118%
Nautilus Biotechnology, Inc. 40.21 Million USD 9.109%
SAB Biotherapeutics, Inc. 26.64 Million USD -37.187%
G1 Therapeutics, Inc. 86.15 Million USD 57.577%
Bellerophon Therapeutics, Inc. 5.4 Million USD -576.708%
Sage Therapeutics, Inc. 82.74 Million USD 55.83%
Ocugen, Inc. 23.98 Million USD -52.395%
Mind Medicine (MindMed) Inc. 46.4 Million USD 21.242%
Q32 Bio Inc. 233.12 Million USD 84.322%
Brainstorm Cell Therapeutics Inc. 9.06 Million USD -303.144%
Alumis Inc. Common Stock 53.5 Million USD 31.687%
Equillium, Inc. 27.95 Million USD -30.733%
Kyverna Therapeutics, Inc. 206.59 Million USD 82.309%
Coya Therapeutics, Inc. 5.62 Million USD -549.568%
CNS Pharmaceuticals, Inc. 6.13 Million USD -495.943%
Dominari Holdings Inc. 4.63 Million USD -688.544%
Edesa Biotech, Inc. 1.84 Million USD -1884.593%
vTv Therapeutics Inc. 29.56 Million USD -23.614%
Bio-Techne Corporation 744.34 Million USD 95.09%
Agios Pharmaceuticals, Inc. 126.09 Million USD 71.016%
Harmony Biosciences Holdings, Inc. 344.45 Million USD 89.389%
Prelude Therapeutics Incorporated 40.57 Million USD 9.922%
Candel Therapeutics, Inc. 28.95 Million USD -26.218%
iTeos Therapeutics, Inc. 92.36 Million USD 60.428%
Nkarta, Inc. 105.6 Million USD 65.389%
BioCardia, Inc. 4.59 Million USD -696.275%
Iterum Therapeutics plc 32.66 Million USD -11.901%